Nepal vs Palau: Statin use vs. average non-HDL cholesterol levels
Nepal
3.2
in 2018
Palau
3.2
in 2018
Nepal rank
118th
Palau rank
118th
Statin use vs. average non-HDL cholesterol levels over time
- Nepal
- Palau
How they compare
Nepal currently reports 3.2 against 3.2 in Palau, a difference of 0.
Across all 39 years both countries report, Palau has been ahead every year.
Nepal ranks 118th and Palau ranks 118th of 191 countries.
Palau has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Nepal | Palau | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 2.85 | 3.77 | 0.92 | Palau |
| 1990s | 2.97 | 3.78 | 0.81 | Palau |
| 2000s | 3.07 | 3.56 | 0.49 | Palau |
| 2010s | 3.14 | 3.31 | 0.1667 | Palau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher statin use vs. average non-hdl cholesterol levels, Nepal or Palau?
- Nepal, at 3.2 against 3.2 in Palau as of 2018.
- What is the difference in statin use vs. average non-hdl cholesterol levels between Nepal and Palau?
- 0, with Nepal ahead.
- How many years of comparable data are there for Nepal and Palau?
- 39 years are reported by both, from 1980 to 2018.
- How do Nepal and Palau rank globally for statin use vs. average non-hdl cholesterol levels?
- Nepal ranks 118th and Palau ranks 118th of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.